GILEAD SCIENCES INC/ US3755581036 /
| - - | Diff. - | Volumen | Geld- | Brief- | Marktkapitalisierung | Dividendenr. | KGV |
|---|---|---|---|---|---|---|---|
| -USD | - | - Umsatz: - |
-Geld Vol: - | -Brief Vol: - | 114,79 Mrd.USD | 3,26% | 20,29 |
Aktiva
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sachanlagen | 701,2000 | 774,4000 | 1.100,3000 | 1.166,2000 | 1.674 | ||||||
| Immaterielle Vermögensgegenstände | 1.425,6000 | 2.067 | 11.736,4000 | 11.900,1000 | 11.073 | ||||||
| Finanzanlagen | 3.219,4000 | 63,7000 | 719,8000 | 439 | 1.598 | ||||||
| Anlagevermögen | - | - | - | - | 16.950 | ||||||
| Vorräte | 1.203,8000 | 1.390 | 1.745 | 2.055,8000 | 1.386 | ||||||
| Forderungen | 1.622 | 1.951,2000 | 1.751,4000 | 2.100,3000 | 4.635 | ||||||
| Liquide Mitteln | 907,9000 | 9.883,8000 | 1.803,7000 | 2.112,8000 | 10.027 | ||||||
| Umlaufvermögen | 5.708,1000 | 13.918,8000 | 6.156,3000 | 7.273,8000 | 17.714 | ||||||
| Aktiva, gesamt | 11.592,6000 | 17.303,1000 | 21.239,8000 | 22.496,8000 | 34.664 | ||||||
Passiva
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Verbindlichkeiten aus Lieferungen und Leistungen | 803 | 1.206,1000 | 1.327,3000 | 1.255,9000 | 955 | ||||||
| Langfristige Schulden | - | - | - | - | 11.921 | ||||||
| Verbindlichkeiten gegenüber Kreditinstituten | - | - | - | - | - | ||||||
| Rückstellungen | 1,9000 | 40,6000 | 13,4000 | 94,2000 | 156 | ||||||
| Verbindlichkeiten | 5.470,8000 | 10.435,8000 | 11.688,9000 | 10.752,3000 | 18.845 | ||||||
| Gezeichnetes Kapital | ,8000 | ,8000 | ,8000 | 1,5340 | 2 | ||||||
| Eigenkapital | 5.863,7000 | 6.738,9000 | 9.309,7000 | 11.369,1000 | 15.819 | ||||||
| Minderheitenanteile | 258,1000 | 128,5000 | 241,1000 | 375,4000 | 393 | ||||||
| Passiva, gesamt | 11.592,6000 | 17.303,1000 | 21.239,8000 | 22.496,8000 | 34.664 | ||||||
Gewinn- und Verlustrechnung
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 7.949,4000 | 8.385,4000 | 9.702,5000 | 11.201,7000 | 24.890 | ||||||
| Abschreibungen (Gesamt) | - | - | - | - | 125 | ||||||
| Betriebsergebnis | 3.962,2000 | 3.789,8000 | 4.010,2000 | 4.524 | 15.265 | ||||||
| Zinsergebnis | -48,7000 | -138,8000 | -360,9000 | -306,9000 | -412 | ||||||
| Ergebnis vor Steuern | 3.913,5000 | 3.651 | 3.612 | 4.208,2000 | 14.856 | ||||||
| Ertragsteuern | 1.023,8000 | 861,9000 | 1.038,4000 | 1.150,9000 | 2.797 | ||||||
| Gewinnanteil Minderheitsgesellschafter | 11,5000 | 14,6000 | 18 | 17,5000 | 42 | ||||||
| Konzernjahresüberschuss | 2.901,3000 | 2.803,6000 | 2.591,6000 | 3.074,8000 | 12.101 | ||||||
Pro Aktie
Cash Flow
|
2010 US GAAP in Mio. USD |
2011 US GAAP in Mio. USD |
2012 US GAAP in Mio. USD |
2013 US GAAP in Mio. USD |
2014 US GAAP in Mio. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow aus laufender Geschäftstätigkeit | 2.833,9000 | 3.639 | 3.194,7000 | 3.105 | 12.818 | ||||||
| Cash Flow aus Investitionstätigkeit | -1.937,8000 | 3.589,8000 | -11.846,1000 | -254,4000 | -1.823 | ||||||
| Cash Flow aus Finanzierungstätigkeit | -1.338,7000 | 1.763,6000 | 563,3000 | -2.543,9000 | -3.025 | ||||||
| Veränderung der liquiden Mittel | -365,1000 | 8.975,9000 | -8.080,1000 | 309,1000 | 7.914 | ||||||
| Anzahl der Mitarbeiter | 4.000 | 4.500 | 5.000 | 6.100 | 7.000 | ||||||
